Plus Therapeutics, Inc.(PSTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PSTV Plus Therapeutics, Inc.

Not Yet Opened 02-04 16:00:00 EST

0.2421

+0.0016

+0.67%

盘后0.2390

-0.0031-1.28%

19:42 EST

High0.2423	Low0.2301	Vol5.67M
Open0.2400	D1 Closing0.2405	Amplitude5.05%
Mkt Cap43.18M	Tradable Cap43.18M	Total Shares178.37M
T/O1.34M	T/O Rate3.18%	Tradable Shares178.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PSTV","market":"US","secType":"STK","nameCN":"Plus Therapeutics, Inc.","latestPrice":0.2421,"timestamp":1770238800000,"preClose":0.2405,"halted":0,"volume":5670006,"hourTrading":{"tag":"盘后","latestPrice":0.239,"preClose":0.2421,"latestTime":"19:42 EST","volume":171150,"amount":40565.3215,"timestamp":1770252120528,"change":-0.0031,"changeRate":-0.012805,"amplitude":0.029327},"delay":0,"changeRate":0.006652806652806728,"floatShares":178371232,"shares":178371232,"eps":-0.455966,"marketStatus":"Not Yet Opened","change":0.0016,"latestTime":"02-04 16:00:00 EST","open":0.24,"high":0.24225,"low":0.2301,"amount":1335280.9697942398,"amplitude":0.05052,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.455966,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770282000000},"marketStatusCode":0,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":0.2405,"preHourTrading":{"tag":"盘前","latestPrice":0.24,"preClose":0.2405,"latestTime":"09:22 EST","volume":79648,"amount":19121.582009280002,"timestamp":1770214940545,"change":-0.0005,"changeRate":-0.002079,"amplitude":0.069854},"postHourTrading":{"tag":"盘后","latestPrice":0.239,"preClose":0.2421,"latestTime":"19:42 EST","volume":171150,"amount":40565.3215,"timestamp":1770252120528,"change":-0.0031,"changeRate":-0.012805,"amplitude":0.029327},"volumeRatio":0.445352},"requestUrl":"/m/hq/s/PSTV","defaultTab":"news","newsList":[{"id":"2608874567","title":"Plus Therapeutics initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2608874567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608874567?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:40","pubTimestamp":1770126032,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer initiated coverage of Plus Therapeutics (PSTV) with a Buy rating and $2 price target Plus recently relaunched CNSid...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-initiated-with-a-buy-at-lake-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-initiated-with-a-buy-at-lake-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSTV","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2605406524","title":"Maxim Group Sticks to Their Buy Rating for Plus Therapeutics (PSTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605406524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605406524?lang=en_us&edition=fundamental","pubTime":"2026-01-23 22:36","pubTimestamp":1769178988,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy maintained a Buy rating on Plus Therapeutics yesterday and set a price target of $1.50. According to TipRanks, M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-plus-therapeutics-pstv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-plus-therapeutics-pstv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSTV"],"gpt_icon":0},{"id":"2605996794","title":"Plus Therapeutics announces anticipated milestones for FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2605996794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605996794?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:50","pubTimestamp":1769086220,"startTime":"0","endTime":"0","summary":"Plus Therapeutics (PSTV) provided a business update and highlights REYOBIQ clinical progress and CNSide US commercialization. “Our 2 key goals in 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-announces-anticipated-milestones-for-fy26-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-announces-anticipated-milestones-for-fy26-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PSTV","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2605293496","title":"Plus Therapeutics Inc - Reyobiq Phase 2 Trial Data Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2605293496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605293496?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:45","pubTimestamp":1769085900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA6NT2P9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSTV","BK4139"],"gpt_icon":0},{"id":"2605443507","title":"BRIEF-Plus Therapeutics To Provide Business Update On Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605443507?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:02","pubTimestamp":1769032964,"startTime":"0","endTime":"0","summary":"BRIEF-Plus Therapeutics To Provide Business Update On ThursdayJan 21 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS TO PROVIDE BUSINESS UPDATE AND HOST CONFERENCE CALL ON THURSDAY, JANUARY","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA1BV0CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2605435301","title":"Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435301","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435301?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:15","pubTimestamp":1769030100,"startTime":"0","endTime":"0","summary":"HOUSTON, Jan.  21, 2026  (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/21/3223245/0/en/Plus-Therapeutics-to-Provide-Business-Update-and-Host-Conference-Call-on-Thursday-January-22-2026-at-9-00-A-M-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4561","BK4135","PSTV","BK4181","ET","LENZ","HST","BK4539","CNS","BK4585","BK4588","BK4590","BK4581","BK4144","BK4007","BK4139"],"gpt_icon":0},{"id":"2604947680","title":"Benzinga Bulls And Bears: TSMC, Rocket Lab, J.B. Hunt — And Space Stocks Soar","url":"https://stock-news.laohu8.com/highlight/detail?id=2604947680","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604947680?lang=en_us&edition=fundamental","pubTime":"2026-01-17 21:21","pubTimestamp":1768656060,"startTime":"0","endTime":"0","summary":"Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/17/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/17/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/market-summary/26/01/49983763/benzinga-bulls-and-bears-tsmc-rocket-lab-j-b-hunt-and-space-stocks-soar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49983763/benzinga-bulls-and-bears-tsmc-rocket-lab-j-b-hunt-and-space-stocks-soar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0353189763.USD","LU2087625088.SGD","LU2106854487.HKD","LU1363072403.SGD","LU1267930813.SGD","LU0965509101.SGD","LU2133065610.SGD","LU0557290698.USD","LU2089284900.SGD","LU2063271972.USD","LU0359201885.HKD","LU2471134952.CNY","JBHT","LU1712237335.SGD","LU1974910355.USD","LU0251131958.USD","IE0034235188.USD","LU0345770308.USD","LU1791710582.SGD","LU1282649810.SGD","BK4548","LU0098860793.USD","LU2237443549.SGD","LU0238689110.USD","LU1989772923.USD","IE00BFXG1179.USD","LU0488056044.USD","LU1989764664.SGD","LU0823431563.USD","LU2271345857.HKD","BK4602","LU1037948541.HKD","LU1989764748.USD","LU1804176565.USD","TSYW.SI","IE0009354923.USD","IE00BKVL7J92.USD","BK4591","LU0823414478.USD","LU0251142724.SGD","IE00BQXX3F31.USD","LU0742534661.SGD","LU2249611893.SGD","LU2491050071.SGD","IE00BD6J9T35.USD","LU0572939691.SGD","BK4564","MNQmain","LU0541502299.USD","LU0823431647.USD","LU0175139822.USD","LU0323591593.USD","LU0882747503.HKD","LU1720051017.SGD","LU1023057109.AUD","LU1934455863.HKD","LU2023251221.USD","LU2458330169.SGD","03145","BK4609","LU0889566641.SGD","LU2211815571.USD","LU2360108059.USD","LU0106261372.USD","LU0359201612.USD","LU1548497426.USD","BK4588","LU1732799900.SGD","LU2458330243.SGD","BK4532","LU2750360997.AUD","GS","LU0143863784.USD","LU1211504680.USD","IE0002270589.USD","QQQE","LU1868837722.USD","LU0971096721.USD","LU2237443978.SGD","QYLD","QYLG","LU0143863198.USD","LU1720051108.HKD","AI","IE00B19Z3B42.SGD","BK4552","LU1934455194.USD","LU2041044095.USD","BK4512","LU2247934214.USD","LU0689626769.HKD","LU0878005551.USD","LU2360032135.SGD","LU1917777945.USD","LU2111349929.HKD","BK4587","LU2294711713.HKD","LU1868837300.USD","IE00BQXX3C00.GBP","LU0106831901.USD","LU1037948897.HKD","LU2023250504.SGD","LU0158827948.USD","LU0795875086.SGD","LU0965509283.SGD","MS","LU2750360641.GBP","SG9999004220.SGD","LU2211814178.USD","BK4116","LU2471134523.USD","IE00BFXG0V08.USD","LU1868836914.USD","LU1934455277.USD","BK4533","LU2357305700.SGD","BK4585","TSM","LU2092937221.SGD","BK4612","LU2491050154.USD","QLD","QQQM","USAW.SI","LU0048573561.USD","LU1623119135.USD","LU2125154935.USD","USJW.SI","LU2860962120.EUR","BK4127","LU2028103732.USD","LU2237443465.HKD","LU1244550577.SGD","IE00BHPRN162.USD","LU0267386448.USD","LU2506951792.HKD","LU1868836757.USD","LU0264606111.USD","LU0345770993.USD","LU2663582299.SGD","LU0878004406.USD","LU2471134879.HKD","LU2089283258.USD","LU1894683264.USD","SPCE","BK4504","LU2347655156.SGD","LU0823414551.USD","BK4089","BK4528","LU0531971165.HKD","LU1791807156.HKD","BK4139","BK4505","LU0528227936.USD","LU0061475181.USD","SGXZ81514606.USD","LU0950373646.USD","SGXZ51526630.SGD","LU0795875169.SGD","BK4232","LU1282649067.USD","RKLB","LU0359202008.SGD","PSQ","IE00B19Z3581.USD","LU1316542783.SGD","BK4023","BK4543","LU1244550494.USD","LU0289960550.SGD","LU0965508806.USD","LU0965509010.AUD","LU0094547139.USD","QQQY","LU0109392836.USD","IE00BYQQ9H92.USD","LU2357125470.USD","BK4022","LU0158827781.USD","LU2250418816.HKD","LU2298321311.HKD","LU1791710400.SGD","LU2543165471.USD","LU0225283273.USD","IE00BSNM7G36.USD","BK4520","LU0096364046.USD","BK4581","FLY","LU0082616367.USD","LU2237443622.USD","SG9999000418.SGD","LU0719512351.SGD","LU1162221912.USD","IE0004091025.USD","IE00B3M56506.USD","LU2237443895.HKD","IE00BZ199S13.USD",".IXIC","IE00BQXX3D17.EUR","BK4516","LU0882574139.USD","BK4077","SQQQ","BK4527","BK4562","IE00BKPKM429.USD","BK4187","LU0124676726.USD","LU0541501648.USD","LU1074936037.SGD","BK4550","LU1868838027.USD","LU1989772840.SGD","LU2125154778.USD","LU0823421416.USD","BK4554","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1868836591.USD","LU0353189680.USD","LU1244550221.USD","QQQJ","LU0198837287.USD","LU1803068979.SGD","PSTV","BK4526","LU0792757196.USD","IE0004445239.USD","LU0572940350.SGD","LU2471134796.USD","LU0234570918.USD","QID","LU0320765646.SGD","BK4097","LU2237438978.USD","LU0056508442.USD","LU1852331112.SGD","LU2360106780.USD","LU0348723411.USD","LU0823421333.USD","IE00B5TLWC47.USD","LU1894683348.USD","NVIW.SI","LU0889565833.HKD","LU1868837136.USD","BK4503","LU0912757837.SGD","BK4082","BK4551","LU0329931090.USD","LU0329931173.USD","LU2237443382.USD","BK4534","LU2054465674.USD","BK4141","LU0316494557.USD","LU2265009873.SGD","LU0314104364.USD","IE0004086264.USD","SGXZ99366536.SGD","LU0384037296.USD","LU1868837565.USD","TQQQ","LU1508157978.USD","LU2491049909.HKD","LU0642271901.SGD","LU1732800096.USD","NQmain","LU1668664300.SGD","GPIQ","BK4605","LU0006306889.USD"],"gpt_icon":1},{"id":"2604933919","title":"BRIEF-Plus Therapeutics Inc - On Jan 13, Co Enters Underwriting Agreement With Lake Street Capital Markets, Llc - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604933919","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604933919?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:09","pubTimestamp":1768597785,"startTime":"0","endTime":"0","summary":"BRIEF-Plus Therapeutics Inc - On Jan 13, Co Enters Underwriting Agreement With Lake Street Capital Markets, Llc - SEC FilingJan 16  - SEC Filing:PLUS THERAPEUTICS INC - ON JAN 13, CO ENTERS UNDERWRITING AGREEMENT WITH LAKE STREET CAPITAL MARKETS, LLC - SEC FILINGPLUS THERAPEUTICS INC - TO ISSUE 39,473,684 SHARES AND WARRANTS AT $0.38 EACH - SEC FILINGPLUS THERAPEUTICS INC - NET PROCEEDS FROM OFFERING ABOUT $13.3 MILLION - SEC FILINGSource text: [ID:n0001193125-26-015346]Further company coverage: PSTV.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YH1V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2604791967","title":"Plus Therapeutics Inc - to Issue 39,473,684 Shares and Warrants at $0.38 Each - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604791967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604791967?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:08","pubTimestamp":1768597699,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YH1V4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSTV","BK4139"],"gpt_icon":0},{"id":"2603641984","title":"Plus Therapeutics Prices Upsized $15 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603641984","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603641984?lang=en_us&edition=fundamental","pubTime":"2026-01-15 03:49","pubTimestamp":1768420176,"startTime":"0","endTime":"0","summary":"Plus Therapeutics (PSTV) said Wednesday it priced an upsized underwritten public offering of about 39.5 million units at $0.38 each, expected to raise approximately $15 million in gross proceeds.Each ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","PSTV","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2603164526","title":"Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November","url":"https://stock-news.laohu8.com/highlight/detail?id=2603164526","media":"Benzinga","labels":["economic","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603164526?lang=en_us&edition=fundamental","pubTime":"2026-01-15 01:41","pubTimestamp":1768412497,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ad4729b76724ee1369972c52e1f4f65c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49914952/crude-oil-gains-over-1-us-retail-sales-rise-0-6-in-november","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","BCTX","QID","QYLD","IVP","PSQ","QLD","TSYW.SI","QQQJ","USJW.SI","PSTV","MNQmain","BK4154","BK4185","TQQQ",".IXIC","HUBC","BK4139","NVIW.SI","QYLG","QQQY","USAW.SI","CLOV","BK4547","NQmain","BK4134","QQQM","QQQE","GPIQ","IVPR"],"gpt_icon":1},{"id":"2603648757","title":"Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648757","media":"Benzinga_recent_news","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603648757?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:36","pubTimestamp":1768408560,"startTime":"0","endTime":"0","summary":"Plus Therapeutics stock falls in premarket trading after pricing a $15 million public offering, with proceeds set for working capital as the company develops cancer treatments.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/14/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/14/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/penny-stocks/26/01/49912177/penny-cancer-stock-plus-therapeutics-raises-15-million-at-discount-stock-plunges","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/penny-stocks/26/01/49912177/penny-cancer-stock-plus-therapeutics-raises-15-million-at-discount-stock-plunges","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0683600562.USD","LU0203345920.USD","IE00BJJMRX11.SGD","LU0238689110.USD","LU2089984988.USD","SG9999002232.USD","BK4532","LU0107464264.USD","LU0545039389.USD","SG9999018865.SGD","LU0353189680.USD","LU0965509101.SGD","LU0011850046.USD","IE00B19Z9Z06.USD","LU0128525689.USD","LU0882574055.USD","LU1732800096.USD","LU1791710400.SGD","LU2491049909.HKD","IE00B1XK9C88.USD","LU0058720904.USD","LU2461242641.AUD","LU2264538146.SGD","LU1934455863.HKD","LU1854103824.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1732799900.SGD","LU0320765059.SGD","IE00BFSS8Q28.SGD","LU0976567544.SGD","LU1069347547.HKD","LU2362541513.USD","LU0861579265.USD","LU0316494557.USD","LU1718418525.SGD","LU2133065610.SGD","LU0708994859.HKD","SG9999017495.SGD","LU0094547139.USD","LU2211815571.USD","LU0211326755.USD","LU1267930573.SGD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0557290698.USD","LU2362540622.SGD","LU0820561818.USD","LU0795875086.SGD","LU1061106388.HKD","LU2125154778.USD","LU2468319806.SGD","LU1506573853.SGD","LU1914381329.SGD","LU2347655156.SGD","BK4217","LU0528227936.USD","LU1791710582.SGD","LU0158827948.USD","IE00B19Z8W00.USD","IE0002270589.USD","LU1066051498.USD","LU2236285917.USD","LU0203347892.USD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU0354030438.USD","IE00B894F039.SGD","BK4585","LU0661504455.SGD","IE00BJJMRY28.SGD","LU1066051811.HKD","LU1670627923.USD","LU2023251221.USD","LU0097036916.USD","LU2244417387.USD","LU2361045086.USD","LU1035773651.USD","LU0496365809.HKD","LU0029864427.USD","LU1037948897.HKD","LU2111349929.HKD","LU1323610961.USD","SG9999018857.SGD","BK4007","IE00B4R5TH58.HKD","LU1551013342.USD","LU0114720955.EUR","BK4566","LU1934455277.USD","LU0109391861.USD","LU1551013425.SGD","BK4154","SG9999014914.USD","LU0354030511.USD","LU1778281490.HKD","SGXZ31699556.SGD","LU1261432733.SGD","LU0251132253.USD","BK4539","IE00BKVL7J92.USD","LU1119994496.HKD","LU0048584097.USD","LU2089283258.USD","IE00BFSS7M15.SGD","LU1548497426.USD","LU2125154935.USD","IE00B19Z8X17.USD","IE000M9KFDE8.USD","IE00B7KXQ091.USD","SGXZ51526630.SGD","LU2242649171.HKD","LU0211328371.USD","LU2491050071.SGD","IE00BFXG1179.USD","SG9999002224.SGD","IE0004445015.USD","IE00BZ9MQY76.HKD","LU1720051017.SGD","LU1674673691.USD","LU0943347566.SGD","LU1267930227.SGD","LU0198837287.USD","LU0820562030.AUD","LU1066053197.SGD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2324357040.USD","LU1153585028.USD","LU0949170772.SGD","SGXZ99366536.SGD","BK4588","LU0417517546.SGD","IE0002141913.USD","LU0965509283.SGD","LU1496350502.SGD","LU0965509010.AUD","LU0149725797.USD","LU1003077747.HKD","SG9999014880.SGD","LU1023059063.AUD","LU1983299246.USD","IE0009355771.USD","LU1066051225.USD","LU0912757837.SGD","LU1064131342.USD","IE00B19Z9505.USD","LU2279689827.SGD","LU2112291526.USD","LU0079474960.USD","SGXZ81514606.USD","LU0122379950.USD","LU1854104046.USD","SG9999014898.SGD","LU0345770993.USD","LU0432979614.USD","LU0738911758.USD","LU0820561909.HKD","LU0672654240.SGD","LU2028103732.USD","LU0052756011.USD","LU0353189763.USD","LU2089284900.SGD","BK4533","PSTV","LU1267930490.SGD","LU0787776722.HKD","LU0289739699.SGD","LU0187121727.USD","LU0211326839.USD","LU1934455194.USD","LU1291159041.SGD","LU0234572021.USD","LU1674673428.USD","LU0256863811.USD","LU1720051108.HKD","LU0708995401.HKD","LU1670628061.USD","SG9999014906.USD","LU0053666078.USD","BK4139","LU2491050154.USD","IE00B19Z3B42.SGD","LU1988902786.USD","IE0004445239.USD","LU0310800965.SGD","LU0310800379.SGD","LU0553294199.USD","LU0823416689.USD","LU2552382215.SGD","LU2552382058.USD","LU0689472784.USD","LU2362541273.HKD","LU0456855351.SGD","IE00B1BXHZ80.USD","LU0342679015.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU2357305700.SGD","LU0345770308.USD","LU0266013472.USD","LU1037948541.HKD","LU2361044865.SGD","LU2552382132.HKD","LU1989771016.USD","IE00B7SZLL34.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1074936037.SGD","SGXZ57979304.SGD","SG9999001176.USD","BK4581","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU0211327993.USD","LU0310799852.SGD","LU1084165304.USD","IE00B19Z3581.USD","LU2271345857.HKD","BK4534","LU1814569148.SGD","LU2360032135.SGD","LU2361044949.HKD","IE00B775H168.HKD","LU0795875169.SGD","IE00BN29S564.USD","LU0965508806.USD","LU0128525929.USD","IE00BSNM7G36.USD","LU0077335932.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2603616745","title":"Plus Therapeutics prices 39.5M units at 38c in upsized public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616745","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616745?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:17","pubTimestamp":1768396673,"startTime":"0","endTime":"0","summary":"Plus Therapeutics (PSTV) announces the pricing of its underwritten public offering of 39,473,684 units, with each unit consisting of one share of c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-prices-39-5m-units-at-38c-in-upsized-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/plus-therapeutics-prices-39-5m-units-at-38c-in-upsized-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PSTV","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2603166686","title":"Plus Therapeutics Inc - Each Unit Sold at $0.38, Gross Proceeds Expected $15 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2603166686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603166686?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:00","pubTimestamp":1768395601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nTUA7QZMYM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSTV","BK4139"],"gpt_icon":0},{"id":"2603616946","title":"Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616946","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616946?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:00","pubTimestamp":1768395600,"startTime":"0","endTime":"0","summary":"HOUSTON, Jan.  14, 2026  (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218538/0/en/Plus-Therapeutics-Announces-Pricing-of-Upsized-15-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4135","LENZ","CNS","BK4007","PSTV"],"gpt_icon":0},{"id":"2601361254","title":"BRIEF-Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2601361254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601361254?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:57","pubTimestamp":1767877031,"startTime":"0","endTime":"0","summary":"BRIEF-Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA Jan 8 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS ANNOUNCES READ OUT OF TYPE B MEETING WITH THE FDA WITH GOAL O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7R6D9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2601369082","title":"Plus Therapeutics Announces Read Out of Type B Meeting With the FDA With Goal of Accelerating Approval of Reyobiq™ for Leptomeningeal Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369082?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7R6D9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2601369034","title":"Plus Therapeutics Inc - FDA Recommends Study Evaluate Endpoint With Clinical Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369034?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7R6D9B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2601087369","title":"Plus Therapeutics Inc - FDA Indicates Accelerated Approval May Be Appropriate for Lm","url":"https://stock-news.laohu8.com/highlight/detail?id=2601087369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601087369?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7R6D9B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"2590137965","title":"CNSide Diagnostics Expands CNSide Assay Platform to California","url":"https://stock-news.laohu8.com/highlight/detail?id=2590137965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590137965?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:30","pubTimestamp":1765456259,"startTime":"0","endTime":"0","summary":"Plus Therapeutics' Subsidiary CNSide Diagnostics Expands CNSide Assay Platform to California. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL37f8S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4585","LU2210149790.SGD","LU2095319765.USD","BK4139","BK4588","LU2210150020.SGD","PSTV","BK4112","SG9999014005.SGD","SG9999014013.SGD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":1}],"profile":{"websiteUrl":"http://plustherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0289},{"period":"1month","weight":-0.5684},{"period":"3month","weight":-0.5288},{"period":"6month","weight":-0.6955},{"period":"1year","weight":-0.8063},{"period":"ytd","weight":-0.5274}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186Re obisbemeda, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.059718},{"month":2,"riseRate":0.541667,"avgChangeRate":0.021138},{"month":3,"riseRate":0.391304,"avgChangeRate":-0.044696},{"month":4,"riseRate":0.347826,"avgChangeRate":-0.02768},{"month":5,"riseRate":0.478261,"avgChangeRate":0.361181},{"month":6,"riseRate":0.25,"avgChangeRate":-0.076657},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.003883},{"month":8,"riseRate":0.291667,"avgChangeRate":-0.04175},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.030103},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.062759},{"month":11,"riseRate":0.375,"avgChangeRate":0.007725},{"month":12,"riseRate":0.375,"avgChangeRate":-0.028095}],"exchange":"NASDAQ","name":"Plus Therapeutics, Inc.","nameEN":"Plus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Plus Therapeutics, Inc.(PSTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Plus Therapeutics, Inc.(PSTV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Plus Therapeutics, Inc.,PSTV,Plus Therapeutics, Inc.股票,Plus Therapeutics, Inc.股票老虎,Plus Therapeutics, Inc.股票老虎国际,Plus Therapeutics, Inc.行情,Plus Therapeutics, Inc.股票行情,Plus Therapeutics, Inc.股价,Plus Therapeutics, Inc.股市,Plus Therapeutics, Inc.股票价格,Plus Therapeutics, Inc.股票交易,Plus Therapeutics, Inc.股票购买,Plus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Plus Therapeutics, Inc.(PSTV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Plus Therapeutics, Inc.(PSTV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}